Vaxil Bio Ltd. (formerly Emerge Resources Corp.) is a listed company. Its insiders report their share dealings to SEDI. Nothing new has been filed by managers of Vaxil Bio Ltd. (formerly Emerge Resources Corp.) in twelve months, the latest record being from 26 November 2020.
Our records for Vaxil Bio Ltd. (formerly Emerge Resources Corp.) go back to 2016, with 2 purchases and no sales on the open market in total.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
14 of 14 declarations
Vaxil Bio Ltd. is a biopharmaceutical company focused on developing immunological treatments for cancer and infectious diseases. Formerly known as Emerge Resources Corp., it is listed on the Toronto Stock Exchange.